Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 14, 2015

Primary Completion Date

June 21, 2020

Study Completion Date

June 21, 2020

Conditions
Advanced CancersPain
Interventions
DRUG

Fentanyl Nasal Spray

Fentanyl nasal spray 100 mcg delivered at time 0 (defined as the time when intranasal Fentanyl spray is administered) with a rescue dose allowed at time 0.5 hour (h)

DRUG

Hydromorphone Hydrochloride

Hydromorphone hydrochloride 1.5 mg pushed intravenously (IV) at time 0 (defined as the time of completion of opioid IV push) with a rescue dose allowed at time 0.5 hour (h).

BEHAVIORAL

Phone Call

Study nurse to call patient 24 hours after participation to ask about side effects since taking part in the study. The phone call should last about 5 minutes.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02459964 - Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain | Biotech Hunter | Biotech Hunter